Outset Medical Inc (OM)
2.545
+0.08
(+3.46%)
USD |
NASDAQ |
Apr 24, 16:00
2.545
0.00 (0.00%)
After-Hours: 19:17
Outset Medical Cash from Financing (TTM): 43.65M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 43.65M |
September 30, 2023 | 76.02M |
June 30, 2023 | 74.45M |
March 31, 2023 | 74.45M |
December 31, 2022 | 72.90M |
September 30, 2022 | 8.232M |
June 30, 2022 | 11.89M |
Date | Value |
---|---|
March 31, 2022 | 161.65M |
December 31, 2021 | 160.15M |
September 30, 2021 | 158.34M |
June 30, 2021 | 411.91M |
March 31, 2021 | 261.13M |
December 31, 2020 | 385.68M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
8.232M
Minimum
Sep 2022
411.91M
Maximum
Jun 2021
146.19M
Average
76.02M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
AngioDynamics Inc | -59.25M |
Baxter International Inc | -3.489B |
Allurion Technologies Inc | 95.99M |
Perspective Therapeutics Inc | 0.785M |
Xtant Medical Holdings Inc | 19.69M |